Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Calithera Biosciences, Inc · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
advanced
clear cell renal cell carcinoma, advanced, metastatic rcc, rcc, cb-839, everolimus, cbe, glutaminase inhibitor, glutaminase, tumor metabolism, glutamine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 980038
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.